Condition
Inherited Retinal Diseases
Total Trials
5
Recruiting
2
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 3 (1)
Trial Status
Recruiting2
Active Not Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05957276Active Not RecruitingPrimary
Global Patient Registry of Inherited Retinal Diseases
NCT06651736Not ApplicableRecruitingPrimary
Optimizing Low Vision Rehabilitation in Emotionally Distressed Patients With Inherited Retinal Diseases
NCT06839170Not ApplicableCompletedPrimary
An Assistant Model for IRD Care Needs: A Randomized Control Trial
NCT06699108Phase 3Active Not Recruiting
Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
NCT06749639Early Phase 1RecruitingPrimary
Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy
Showing all 5 trials